# Belite Bio, Inc (BLTE) stock: price and valuation

URL: https://funkfolio.com/stock/BLTE

> Belite Bio, Inc (BLTE) trades at $157.72 and is worth $6.35B. Valuation against its own history and up to 20 years of financials.

---

## Belite Bio, Inc (BLTE)

Belite Bio, Inc (BLTE) is a healthcare company (biotechnology) based in the United States. The share price is $157.72, down 2.98% on the day, which values the company at $6.35B. Price as of 17 Nov 2026, 22:00 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $157.72 −2.98% today
- **Market value:** $6.35B
- **200-week average:** $77.69 103% above
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 22:00 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Belite Bio, Inc in more detail

BLTE trades at -726.4× next year's expected earnings. It sits 103% above its 200-week average of $77.69.

In its favour: More cash than debt. Worth checking: Share count keeps rising; Thin interest cover.

2 of the superinvestors tracked here hold BLTE, including Lee Ainslie (0.6% of the portfolio), Stanley Druckenmiller (0.4% of the portfolio).

### Superinvestors holding BLTE

2 of the investors tracked here report a position in their latest 13F filing.

- [Lee Ainslie Maverick Capital](https://funkfolio.com/gurus/lee-ainslie) 0.55% of portfolio · $61M · new · Q2 2026
- [Stanley Druckenmiller Duquesne Family Office](https://funkfolio.com/gurus/stanley-druckenmiller) 0.38% of portfolio · $16.3M · Q2 2026

### Health Care companies of similar size

- [MSA Safety MSA](https://funkfolio.com/stock/MSA)
- [CG Oncology CGON](https://funkfolio.com/stock/CGON)
- [Kodiak Sciences KOD](https://funkfolio.com/stock/KOD)
- [Lantheus Holdings LNTH](https://funkfolio.com/stock/LNTH)
- [RadNet RDNT](https://funkfolio.com/stock/RDNT)
- [Ligand Pharmaceuticals LGND](https://funkfolio.com/stock/LGND)
- [Scholar Rock Holding SRRK](https://funkfolio.com/stock/SRRK)
- [Teleflex TFX](https://funkfolio.com/stock/TFX)
- [Mirum Pharmaceuticals MIRM](https://funkfolio.com/stock/MIRM)
- [Veradermics MANE](https://funkfolio.com/stock/MANE)
- [Grifols GRFS](https://funkfolio.com/stock/GRFS)
- [Cogent Biosciences COGT](https://funkfolio.com/stock/COGT)

Side by side: [BLTE vs LGND (Belite Bio, Inc vs Ligand Pharmaceuticals)](https://funkfolio.com/compare/blte-vs-lgnd) [BLTE vs RDNT (Belite Bio, Inc vs RadNet)](https://funkfolio.com/compare/blte-vs-rdnt) [BLTE vs SRRK (Belite Bio, Inc vs Scholar Rock Holding)](https://funkfolio.com/compare/blte-vs-srrk) [BLTE vs TFX (Belite Bio, Inc vs Teleflex)](https://funkfolio.com/compare/blte-vs-tfx) [BLTE vs MIRM (Belite Bio, Inc vs Mirum Pharmaceuticals)](https://funkfolio.com/compare/blte-vs-mirm)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Belite Bio, Inc (BLTE): questions and answers

**What is Belite Bio, Inc's market cap?**

Belite Bio, Inc is valued at $6.35B at a share price of $157.72.

**Is BLTE above its 200-week moving average?**

Yes. BLTE is 103.0% above its 200-week average of $77.69. Long-term investors watch that line because strong companies rarely trade below it for long.

**Does BLTE pay a dividend?**

Belite Bio, Inc does not currently pay a regular dividend.

**Which famous investors own BLTE?**

In their latest quarterly filings, Lee Ainslie (0.6% of the portfolio), Stanley Druckenmiller (0.4% of the portfolio) hold BLTE. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Belite Bio, Inc (BLTE) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/BLTE

Underlying data: Yahoo Finance; company filings with the SEC.
